FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,756,000 | +551.5% | 162,000 | +80.0% | 0.09% | +447.1% |
| Q3 2020 | $423,000 | -23.0% | 90,000 | 0.0% | 0.02% | -29.2% |
| Q2 2020 | $549,000 | +169.1% | 90,000 | 0.0% | 0.02% | +118.2% |
| Q1 2020 | $204,000 | -50.6% | 90,000 | 0.0% | 0.01% | -35.3% |
| Q4 2019 | $413,000 | +18.3% | 90,000 | 0.0% | 0.02% | +13.3% |
| Q3 2019 | $349,000 | -35.7% | 90,000 | 0.0% | 0.02% | -40.0% |
| Q2 2019 | $543,000 | -55.0% | 90,000 | 0.0% | 0.02% | -55.4% |
| Q1 2019 | $1,206,000 | +44.1% | 90,000 | 0.0% | 0.06% | +40.0% |
| Q4 2018 | $837,000 | -33.2% | 90,000 | 0.0% | 0.04% | -29.8% |
| Q3 2018 | $1,253,000 | -11.9% | 90,000 | 0.0% | 0.06% | +1.8% |
| Q2 2018 | $1,423,000 | -8.0% | 90,000 | 0.0% | 0.06% | -9.7% |
| Q1 2018 | $1,546,000 | -11.9% | 90,000 | +12.5% | 0.06% | -7.5% |
| Q4 2017 | $1,754,000 | – | 80,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |